Phase 4 Study of Atorvastatin 10mg vs. 40mg in Follow-up CFR in AMI [acute myocardial infarction] Patients.

Trial Profile

Phase 4 Study of Atorvastatin 10mg vs. 40mg in Follow-up CFR in AMI [acute myocardial infarction] Patients.

Completed
Phase of Trial: Phase IV

Latest Information Update: 06 Apr 2012

At a glance

  • Drugs Atorvastatin (Primary)
  • Indications Atherosclerosis; Myocardial infarction
  • Focus Biomarker; Pharmacodynamics; Therapeutic Use
  • Most Recent Events

    • 07 Jun 2017 Biomarkers information updated
    • 01 May 2010 Results published in Heart (British Cardiac Society).
    • 14 Mar 2010 Results presented at the 59th Annual Scientific Session of the American College of Cardiology.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top